143 CLINICAL CONSEQUENCES OF OFF-LABEL REDUCED DOSING OF NOACS IN AF FIGURE 2: META-ANALYSES IN ATRIAL FIBRILLATION PATIENTS WITH OFF-LABEL REDUCED DOSING OF A NOAC VERSUS ON-LABEL NON-REDUCED DOSING OF A NOAC. A. With outcome (ischaemic) stroke (and TIA and/or thromboembolism) B. With outcome bleeding 8
RkJQdWJsaXNoZXIy MTk4NDMw